Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
INNOVATE Corp ( (VATE) ) has issued an update.
INNOVATE Corp. reported on March 26, 2026 that its fourth-quarter 2025 revenue rose 61.7% year-on-year to $382.7 million and full-year 2025 revenue increased 12.5% to $1.25 billion, driven mainly by its Infrastructure arm, while net loss attributable to common and participating preferred stockholders narrowed to $7.8 million for the quarter and $64.0 million for the year. The Infrastructure segment, led by DBM Global, posted a 65.7% revenue jump in the quarter, expanded its reported backlog to $1.7 billion and adjusted backlog to $1.8 billion by year-end 2025, reinforcing visibility into 2026 despite some margin compression.
In Life Sciences, MediBeacon secured U.S. FDA approval for its next-generation TGFRTM system and began a Center of Excellence commercial rollout, while R2 restructured its China distribution deal and obtained a three-year minimum commitment for 600 systems, even as quarterly revenue declined but full-year sales and unit volumes rose. The Spectrum segment faced softer advertising and customer terminations that weighed on quarterly results, but management highlighted favorable FCC rulings, new UHF upgrades, expansion into over 40 new markets and successful mobile carrier trials as catalysts expected to improve performance from 2026, positioning INNOVATE for stronger operational momentum across its portfolio.
The most recent analyst rating on (VATE) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on INNOVATE Corp stock, see the VATE Stock Forecast page.
Spark’s Take on VATE Stock
According to Spark, TipRanks’ AI Analyst, VATE is a Neutral.
The score is held back primarily by weak financial quality (loss-making profile and balance-sheet stress with negative equity), despite improving cash flow and revenue growth. Technical momentum is supportive (price above key moving averages with positive MACD), and earnings-call updates show growth/backlog strength but also meaningful margin pressure and elevated debt.
To see Spark’s full report on VATE stock, click here.
More about INNOVATE Corp
INNOVATE Corp., listed on the NYSE under the ticker VATE, operates a diversified portfolio across infrastructure services, life sciences and broadcast spectrum assets. Its key businesses include DBM Global in structural steel fabrication and construction services, MediBeacon and R2 Technologies in medical technology, and a Spectrum segment focused on low-power television broadcasting and data delivery partnerships in U.S. markets.
Average Trading Volume: 17,144
Technical Sentiment Signal: Sell
Current Market Cap: $55.71M
For an in-depth examination of VATE stock, go to TipRanks’ Overview page.